Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Santi, Adriana ^a   Duarte, Marta M M F ^a   De Menezes, Charlene C ^a   Loro, Vania Lucia ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLESTERASE; BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; LIPID ANALYSIS; LIPID PEROXIDATION; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84871359156     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/856359     Document Type: Article

References (52)

1. Razvi S., Shakoor A., Vanderpump M., Weaver J. U., Pearce S. H. S., The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 8 2998 3007 2-s2.0-49149106491 10.1210/jc.2008-0167
2. Hueston W. J., Pearson W. S., Subclinical hypothyroidism and the risk of hypercholesterolemia. Annals of Family Medicine 2004 2 4 351 355 2-s2.0-4243058285 10.1370/afm.79 (Pubitemid 39107893)
3. Donnini D., Ambesi-Impiombato F. S., Curcio F., Thyrotropin stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 2003 13 6 517 521 2-s2.0-0038506971 (Pubitemid 36842656)
4. Becerra A., Bellido D., Luengo A., Piédrola G., De Luis D. A., Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clinical Nutrition 1999 18 5 319 322 2-s2.0-0032699772 10.1016/S0261-5614(98)80031-9 (Pubitemid 29527743)
5. Wiseman S. A., Powell J. T., Humphries S. E., Press M., The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. Journal of Clinical Endocrinology and Metabolism 1993 77 1 108 112 2-s2.0-0027199665 10.1210/jc.77.1.108 (Pubitemid 23206786)
6. Mya M. M., Aronow W. S., Subclinical hypothyroidism is associated with coronary artery disease in older persons. Journals of Gerontology A 2002 57 10 M658 M659 2-s2.0-0036786871
7. Geul K. W., Van Sluisveld I. L. L., Grobbee D. E., Docter R., De Bruyn A. M., Hooykaas H., Van Der Merwe J. P., Van Hemert A. M., Krenning E. P., Hennemann G., Weber R. F. A., The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clinical Endocrinology 1993 39 3 275 280 2-s2.0-0027320753 (Pubitemid 23274425)
8. Al-Tonsi A. A., Abdel-Gayoum A. A., Saad M., The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. Experimental and Molecular Pathology 2004 76 2 182 187 2-s2.0-1542268975 10.1016/j.yexmp. 2003.10.006 (Pubitemid 38316933)
9. Coria M. J., Pastrán A. I., Gimenez M. S., Serum oxidative stress parameters of women with hypothyroidism. Acta Biomedica de l'Ateneo Parmense 2009 80 2 135 139 2-s2.0-73349127833
10. Messarah M., Boumendjel A., Chouabia A., Klibet F., Abdennour C., Boulakoud M. S., Feki A. E., Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Experimental and Toxicologic Pathology 2010 62 3 301 310 2-s2.0-77952891501 10.1016/j.etp.2009. 04.009
11. Dumitriu L., Bartoc R., Ursu H., Purice M., Ionescu V., Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie 1988 26 1 35 38 2-s2.0-0023676829
12. Konukoglu D., Ercan M., Hatemi H., Plasma viscosity in female patients with hypothyroidism: effects of oxidative stress and cholesterol. Clinical Hemorheology and Microcirculation 2002 27 2 107 113 2-s2.0-0036037494 (Pubitemid 35024998)
13. Torun A. N., Kulaksizoglu S., Kulaksizoglu M., Pamuk B. O., Isbilen E., Tutuncu N. B., Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clinical Endocrinology 2009 70 3 469 474 2-s2.0-60349094682 10.1111/j.1365-2265.2008. 03348.x
14. Bouderbala S., Lamri-Senhadji M., Prost J., Lacaille-Dubois M. A., Bouchenak M., Changes in antioxidant defense status in hypercholesterolemic rats treated with Ajuga iva. Phytomedicine 2008 15 6-7 453 461 2-s2.0-44749091784 10.1016/j.phymed.2007.10.001
15. Nanda N., Bobby Z., Hamide A., Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clinical and Experimental Medicine 2008 8 2 101 108 2-s2.0-47349090825 10.1007/s10238-008-0164-0 (Pubitemid 351999729)
16. Kebapcilar L., Akinci B., Bayraktar F., Comlekci A., Solak A., Demir T., Yener S., Küme T., Yesil S., Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Medical Principles and Practice 2007 16 6 432 436 2-s2.0-35148817413 10.1159/000107747 (Pubitemid 47538123)
17. Serdar Z., Aslan K., Dirican M., Sarandöl E., Yeşilbursa D., Serdar A., Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clinical Biochemistry 2006 39 8 794 803 2-s2.0-33746911144 10.1016/j.clinbiochem.2006.02.004 (Pubitemid 44201186)
18. Das K., Chainy G. B. N., Thyroid Hormone influences antioxidant defense system in adult rat brain. Neurochemical Research 2004 29 9 1755 1766 2-s2.0-4043069907 10.1023/B:NERE.0000035812.58200.a9 (Pubitemid 39070067)
19. Senthil S., Veerappan R. M., Ramakrishna Rao M., Pugalendi K. V., Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clinica Chimica Acta 2004 348 1-2 131 137 2-s2.0-4444226990 10.1016/j.cccn.2004.05.004 (Pubitemid 39209011)
20. Mackness B., Durrington P. N., Mackness M. I., The paraoxonase gene family and coronary heart disease. Current Opinion in Lipidology 2002 13 4 357 362 2-s2.0-0036321308 10.1097/00041433-200208000-00002 (Pubitemid 34831938)
21. Quéméneur T., Martin-Nizard F., Kandoussi A., Kyndt X., Vanhille P., Hachulla E., Hatron P. Y., Fruchart J. C., Duriez P., Lambert M., PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis. Seminars in Arthritis and Rheumatism 2007 37 3 149 155 2-s2.0-36348998621 10.1016/j.semarthrit.2007.03.002 (Pubitemid 350153648)
22. Olivero-David R., Schultz-Moreira A., Vázquez-Velasco M., González-Torres L., Bastida S., Benedí J., Sanchez-Reus M. I., González-Muñoz M. J., Sánchez-Muniz F. J., Effects of Nori- and Wakame-enriched meats with or without supplementary cholesterol on arylesterase activity, lipaemia and lipoproteinaemia in growing Wistar rats. British Journal of Nutrition 2011 106 1476 1486
23. Luboshitzky R., Aviv A., Herer P., Lavie L., Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002 12 5 421 425 2-s2.0-0035986940 (Pubitemid 34602602)
24. Bachorik P. S., Albers J. J., Precipitation methods for quantification of lipoproteins. Methods in Enzymology 1986 129 78 100 2-s2.0-0022556171 (Pubitemid 16055941)
25. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
26. Jentzsch A. M., Bachmann H., Fürst P., Biesalski H. K., Improved analysis of malondialdehyde in human body fluids. Free Radical Biology and Medicine 1996 20 2 251 256 2-s2.0-0030042539 10.1016/0891-5849(95)02043-8 (Pubitemid 26021882)
27. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441 10.1016/S0076-6879(84)05016-3
28. McCord J. M., Fridovich I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 1969 244 22 6049 6055 2-s2.0-0014691242
29. Bełtowski J., Wójcicka G., Jamroz A., Differential effect of 3-hydroxy-3-methylglutarylcoenzyme a reductase inhibitors on plasma paraoxonase 1 activity in the rat. Polish Journal of Pharmacology 2002 54 6 661 671 2-s2.0-0036968207 (Pubitemid 36124517)
30. Huesca-Gómez C., Franco M., Luc G., Montaño L. F., Massó F., Posadas-Romero C., Pérez-Méndez O., Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 2002 51 4 443 450 2-s2.0-0036114026 10.1053/meta.2002.31323 (Pubitemid 34406559)
31. Efstathiadou Z., Bitsis S., Milionis H. J., Kukuvitis A., Bairaktari E. T., Elisaf M. S., Tsatsoulis A., Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? European Journal of Endocrinology 2001 145 6 705 710 2-s2.0-0035209864 (Pubitemid 33133676)
32. Yildirimkaya M., Özata M., Yilmaz K., Kilinç C., Gündoan M. A., Kutluay T., Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocrine Journal 1996 43 6 731 736 2-s2.0-0030342489 (Pubitemid 126447910)
33. Miura S., Iitaka M., Yoshimura H., Kitahama S., Fukasawa N., Kawakami Y., Sakurai S., Urabe M., Sakatsume Y., Ito K., Ishii J., Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Internal Medicine 1994 33 7 413 417 2-s2.0-0028061185 (Pubitemid 24269857)
34. Turhan S., Sezer S., Erden G., Guctekin A., Ucar F., Ginis Z., Ozturk O., Bingol S., Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism. Annals of Saudi Medicine 2008 28 2 96 101 2-s2.0-43149083312 (Pubitemid 351638160)
35. Lu L., Wang B., Shan Z., Jiang F., Teng X., Chen Y., Lai Y., Wang J., Xue H., Wang S., Li C., Liu H., Li N., Yu J., Shi L., Hou X., Xing Q., Bai X., Teng W., The correlation between thyrotropin and dyslipidemia in a population-based study. Journal of Korean Medical Science 2011 26 2 243 249 2-s2.0-79551667683 10.3346/jkms.2011.26.2.243
36. Taddei S., Caraccio N., Virdis A., Dardano A., Versari D., Ghiadoni L., Salvetti A., Ferrannini E., Monzani F., Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism 2003 88 8 3731 3737 2-s2.0-0041883173 10.1210/jc.2003-030039 (Pubitemid 37034521)
37. Lee W. Y., Suh J. Y., Rhee E. J., Park J. S., Sung K. C., Kim S. W., Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status. Archives of Medical Research 2004 35 6 540 545 2-s2.0-22944460810 10.1016/j.arcmed.2004.08.003 (Pubitemid 41043627)
38. Iqbal A., Jorde R., Figenschau Y., Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. Journal of Internal Medicine 2006 260 1 53 61 2-s2.0-33745173079 10.1111/j.1365-2796.2006.01652.x (Pubitemid 43894070)
39. Venditti P., Di Meo S., Thyroid hormone-induced oxidative stress. Cellular and Molecular Life Sciences 2006 63 4 414 434 2-s2.0-33645073403 10.1007/s00018-005-5457-9
40. Messarah M., Boulakoud M. S., Boumendjel A., Abdennour C., El Feki A., The impact of thyroid activity variations on some oxidizing-stress parameters in rats. Comptes Rendus-Biologies 2007 330 2 107 112 2-s2.0-33846883975 10.1016/j.crvi.2006.11.004 (Pubitemid 46223887)
41. Asayama K., Kato K., Oxidative muscular injury and its relevance to hyperthyroidism. Free Radical Biology and Medicine 1990 8 3 293 303 2-s2.0-0025217863 10.1016/0891-5849(90)90077-V (Pubitemid 20137052)
42. López-Torres M., Romero M., Barja G., Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Molecular and Cellular Endocrinology 2000 168 1-2 127 134 2-s2.0-0034715499 10.1016/S0303-7207(00)00302-6
43. Duarte M. M. M. F., Moresco R. N., Duarte T., Santi A., Bagatini M. D., Da Cruz I. B. M., Schetinger M. R. C., Loro V. L., Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clinical Biochemistry 2010 43 13-14 1118 1123 2-s2.0-77956177703 10.1016/j.clinbiochem.2010.07.002
44. Nanda N., Bobby Z., Hamide A., Koner B. C., Sridhar M. G., Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism: Clinical and Experimental 2007 56 10 1350 1355 2-s2.0-34548656536 10.1016/j.metabol.2007.05.015 (Pubitemid 47404597)
45. Santi A., Duarte M. M. M. F., Moresco R. N., Menezes C., Bagatini M. D., Schetinger M. R. C., Loro V. L., Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clinical Chemistry and Laboratory Medicine 2010 48 11 1635 1639 2-s2.0-78751639476 10.1515/CCLM.2010. 309
46. Aviram M., Rosenblat M., Bisgaier C. L., Newton R. S., Primo-Parmo S. L., La Du B. N., Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. Journal of Clinical Investigation 1998 101 8 1581 1590 2-s2.0-0032522985 (Pubitemid 28198486)
47. Sumegová K., Blažíček P., Waczulíková I., Žitňanová I., Ďuračková Z., Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Acta Biochimica Polonica 2006 53 4 783 787 2-s2.0-33846135726 (Pubitemid 46090127)
48. Cebeci E., Alibaz-Oner F., Usta M., Yurdakul S., Erguney M., Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism. Journal of Investigative Medicine 2012 60 23 28
49. Baskol G., Atmaca H., Tanriverdi F., Baskol M., Kocer D., Bayram F., Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Experimental and Clinical Endocrinology and Diabetes 2007 115 8 522 526 2-s2.0-35848964067 10.1055/s-2007-981457 (Pubitemid 350056765)
50. Ikeda Y., Inoue M., Suehiro T., Arii K., Kumon Y., Hashimoto K., Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes. Acta Diabetologica 2009 46 3 239 242 2-s2.0-69849110325 10.1007/s00592-008-0066-3
51. Shih D. M., Lusis A. J., The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Current Opinion in Lipidology 2009 20 4 288 292 2-s2.0-68449096849 10.1097/MOL.0b013e32832ca1ee
52. Duntas L. H., Mantzou E., Koutras D. A., Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 2002 12 11 1003 1007 2-s2.0-0036854488 (Pubitemid 35404135)